Policy & Legislation
News on government policy and legislation impacting life science and diagnostics.
FIND Intensifies Efforts to Help Countries Determine Best Options for Their Diagnostic Needs
Premium
FIND plans to expand its activities around its diagnostic network optimization process, including the use of its OptiDx platform, to 15 more countries.
The rule calls for using payors' median in-network rates as benchmarks in arbitration, a move labs fear could undermine their negotiating leverage with insurers.
European Commission Adopts Interim Measure to Hold Grail Separate From Illumina
The measures are legally binding for both Illumina and Grail, and compliance with them will be monitored by a trustee to be approved by the commission.
California Bill Prohibiting Prior Authorizations for Cancer Biomarker Testing Becomes Law
The law will restrict insurers from requiring doctors to get coverage approval before ordering biomarker testing for advanced cancer patients.
European laboratories that modify existing assays or make their own tests to better care for patients are staring at a substantial increase in oversight.